Form 4 for KYNB KYNTRA BIO, INC.
Accepted 2023-02-23 00:00:00 ET · period of report 2023-02-21 · accession 0001209191-23-012426 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-23 | 2023-02-21 | KYNB | Chung Christine | SVP, China Ops | A - Grant | $0.00 | +25.0K | 259.9K | +11% | $0 |
| D | 2023-02-23 | 2023-02-21 | KYNB | Chung Christine | SVP, China Ops | A - Grant | $0.00 | +42.0K | 42.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-21 | A | A | 25,000 | $0.00 | 259,873 | D | — | — | (F1) Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2024, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-02-21 | A | A | 42,000 | $0.00 | 42,000 | D | $22.60 · — to 2033-02-20 | 42,000 Common Stock | (F2) Twenty-five percent of the shares subject to the option will vest on March 1, 2024, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years. |